Canadian Life Sciences NewsUncategorized

Lexston Life Sciences Corp. announces DTC Eligibility

Lexston Life Sciences Corp. announces DTC Eligibility

(TheNewswire)


Lexston Life Sciences Corp.

Vancouver, British Columbia –
TheNewswire –
December 15
th, 2021 –
Lexston Life
Sciences Corp. (the “Company” or “Lexston”) (CSE:LEXT)
(CNSX:LEXT.CN)
(OTC:LEXTF)
is pleased to announce that its common shares are now eligible for
electronic clearing and settlement through the Depository Trust
Company (“DTC”) in the United States.

DTC is a subsidiary of the Depository Trust &
Clearing Corporation, a U.S. company that manages the electronic
clearing and settlement of publicly traded companies. Securities that
are eligible to be electronically cleared and settled through DTC are
considered “DTC eligible”. DTC eligibility is expected to
create a seamless process of trading and enhance liquidity of the
Company’s common shares in the United States over time.

The ability to have Lexston’s shares electronically
cleared and settled in the United States is far more convenient and
reduces the costs incurred in trading shares. With Lexston’s shares
now traded electronically, existing investors benefit from greater
liquidity over time and execution speeds, while new investors are far
less restricted from participating in Lexston’s shares. The DTC is
the largest securities depository in the world and facilitates
electronic settlement of stock certificate transfers in the United
States. This electronic method of clearing securities accelerates the
settlement process for investors and brokers.

DTC eligibility compliments Lexston’s recent OTCQB®
Venture Marketplace (the “OTCQB Venture” or “OTCQB”) listing
approval. The OTCQB, operated by the OTC Markets Group in New York, is
the premiere marketplace for early stage and developing U.S. and
international companies and is recognized by the United States
Securities and Exchange Commission (“SEC”) as an established
public market providing public information for analysis and value of
securities. Lexston commenced trading on the under the symbol “LEXTF
(“OTCQB”) on November 12, 2021 and continues to trade on the
Canadian Stock Exchange (“CSE”) under the symbol
“LEXT”.

For more information and to subscribe to the
Company’s mailing list, please visit
https://lexston.ca/contact/

About Lexston Life Sciences
Corp.

Lexston Life Sciences Corp. is a Canadian biotechnology
company providing cannabis testing and research services. Lexston is
also in the process of securing licensing under the exemptions
prescribed by section 56 of the Controlled Drugs and Substances Act
(Canada) to enable the expansion of its services into the psychedelic
industry with an initial focus on the detection and quantification of
psychedelic molecules in the lab and point of care. Lexston intends to
develop and validate methods for standardized manufacturing of plant
derived psychedelics in support of burgeoning trials in the field of
mental health and wellness.

On Behalf of the Board of Directors

LEXSTON LIFE SCIENCES CORP.

Jagdip Bal Chief Executive Officer

Telephone: (604) 928-8913

Forward-Looking Statements

This news release contains forward-looking statements
and information within the meaning of applicable securities
legislation. Often, but not always, forward-looking statements and
information can be identified by the use of words such as “plans”,
“expects” or “does not expect”, “is expected”,
“estimates”, “intends”, “anticipates” or “does not
anticipate”, or “believes”, or variations of such words and
phrases or state that certain actions, events
or
results “may”, “could”, “would”, “might” or “will”
be taken, occur or be achieved. Forward looking statements or
information involve known and unknown risks, uncertainties and other
factors which may cause the actual results, performance, or
achievements of LEXT to be materially different from any future
results, performance or achievements expressed or implied by the
forward-looking statements or information contained in this news
release.

Risks, uncertainties, and other factors involved with
forward-looking information could cause actual events, results,
performance, prospects, and opportunities to differ materially from
those expressed or implied by such forward-looking information. The
Canadian Securities Exchange has not reviewed and does not accept
responsibility for the adequacy or accuracy of the content of this
news release.

Copyright (c) 2021 TheNewswire – All rights reserved.

Related Articles

Back to top button